Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pelz

Showing results (751-760 of 835) with videos related to

Pageof 84
Sort By:
The Lancet. Gastroenterology & Hepatology|August 19, 2024
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trialKlara Dorman, Stefan Boeck, Karel Caca, et al.
Nature Communications|November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Research Square|March 27, 2026
Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B CellsNiels von Wardenburg, Gregorio Spagni, S Reincke, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Fate of extrahepatic human stem and precursor cells after transplantation into mouse liversMarc Brulport, Wiebke Schormann, Alexander Bauer, et al.
Radiology|April 22, 2008
White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion studyBlake D Murphy, Allan J Fox, Donald H Lee, et al.
International Journal of Cancer|June 5, 2019
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trialOleg Gluz, Cornelia Kolberg-Liedtke, Aleix Prat, et al.
Scientific Reports|October 9, 2023
Fully automated sequential immunofluorescence (seqIF) for hyperplex spatial proteomicsFrançois Rivest, Deniz Eroglu, Benjamin Pelz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2025
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and CachexiaInna M Chen, Julia S Johansen, Susann Theile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2016
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc TrialO Gluz, C Liedtke, J Huober, et al.
Stroke|June 10, 2006
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurementsB D Murphy, A J Fox, D H Lee, et al.
Pageof 84

Showing results (751-760 of 835) with videos related to

Sort By:
Pageof 84
The Lancet. Gastroenterology & Hepatology|August 19, 2024
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trialKlara Dorman, Stefan Boeck, Karel Caca, et al.
Nature Communications|November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Research Square|March 27, 2026
Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B CellsNiels von Wardenburg, Gregorio Spagni, S Reincke, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Fate of extrahepatic human stem and precursor cells after transplantation into mouse liversMarc Brulport, Wiebke Schormann, Alexander Bauer, et al.
Radiology|April 22, 2008
White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion studyBlake D Murphy, Allan J Fox, Donald H Lee, et al.
International Journal of Cancer|June 5, 2019
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trialOleg Gluz, Cornelia Kolberg-Liedtke, Aleix Prat, et al.
Scientific Reports|October 9, 2023
Fully automated sequential immunofluorescence (seqIF) for hyperplex spatial proteomicsFrançois Rivest, Deniz Eroglu, Benjamin Pelz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2025
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and CachexiaInna M Chen, Julia S Johansen, Susann Theile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2016
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc TrialO Gluz, C Liedtke, J Huober, et al.
Stroke|June 10, 2006
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurementsB D Murphy, A J Fox, D H Lee, et al.
Pageof 84